Dyne Therapeutics Inc
(NAS:DYN)
$
26.49
+0.25 (+0.95%)
Market Cap: 4.95 Bil
Enterprise Value: 4.27 Bil
PE Ratio: 0
PB Ratio: 6.25
GF Score: 34/100 Dyne Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 06:00PM GMT
Release Date Price:
$13.46
(-5.74%)
Eun Yang
Jefferies & Company - Analyst
Good afternoon, everybody. This is Eun Yang, a biotech analyst with the Jefferies, based in New York. Next presenting company is Dyne Therapeutics. And this is going to be a fireside chat. Joining me from Dyne are Josh Brumm, President and CEO, and Wildon Farwell, CMO of the company. So, thank you for joining us.
Josh Brumm
Dyne Therapeutics, Inc. - President and CEO
Thank you, Eun.
Wildon Farwell
Dyne Therapeutics, Inc. - Chief Medical Officer
Thank you.
Eun Yang
Jefferies & Company - Analyst
So before we start the Q&A, Josh, would you give us a kind of a brief overview of what Dyne does?
Josh Brumm
Dyne Therapeutics, Inc. - President and CEO
Well, thanks. Thanks again for inviting us here to the conference, Eun and Jefferies. I'm making some forward-looking statements, so please refer to our SEC filings on that matter.
Look, Dyne has been for me, personally,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot